Docetaxel
Showing 51 - 75 of 3,166
Breast Cancer, Chemo Effect Trial (Epirubicin, Cyclophosphamide, Xihuang Pill, Docetaxel, Epirubicin, Cyclophosphamide,
Not yet recruiting
- Breast Cancer
- Chemotherapy Effect
- Epirubicin, Cyclophosphamide, Xihuang Pill, Docetaxel
- Epirubicin, Cyclophosphamide, Docetaxel
- (no location specified)
Jun 21, 2023
Breast Cancer Trial in Shenyang (Pyrotinib, Trastuzumab, Dalpiciclib)
Not yet recruiting
- Breast Cancer
- Pyrotinib
- +7 more
-
Shenyang, Liaoning, ChinaShengjing Hospital of China Medical University
Dec 2, 2022
Prostate Cancer Trial in United States (Docetaxel-PNP, Ribociclib, Prednisone)
Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer Trial in Kyiv (Docetaxel, Oxaliplatin, Leucovorin)
Recruiting
- Gastric Cancer
- +10 more
- Docetaxel
- +3 more
-
Kyiv, UkraineNational Cancer Institute
Aug 31, 2023
Non-small-cell Lung Cancer Trial in China (TQB2450 +Anlotinib+Docetaxel, TQB2450 +Androtinib Placebo+Docetaxel)
Recruiting
- Non-small-cell Lung Cancer
- TQB2450 +Anlotinib+Docetaxel
- TQB2450 +Androtinib Placebo+Docetaxel
-
Huizhou, Guangdong, China
- +4 more
Nov 15, 2023
Pediatric Sarcoma, Refractory, Pediatric Sarcoma, Relapsed Trial in Tampa, Columbus (GEM/DOX + TGFBi expanded NK cells)
Recruiting
- Pediatric Sarcoma, Refractory
- Pediatric Sarcoma, Relapsed
- GEM/DOX + TGFBi expanded NK cells
-
Tampa, Florida
- +1 more
Jan 3, 2023
NSCLC (NSCLC) Trial (MK-2870, Docetaxel, Pemetrexed)
Not yet recruiting
- Non-small Cell Lung Cancer (NSCLC)
- MK-2870
- +2 more
- (no location specified)
Oct 3, 2023
HER2-positive Breast Cancer Trial in Shanghai (SYSA1901, Pertuzumab, Trastuzumab)
Recruiting
- HER2-positive Breast Cancer
- SYSA1901
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Feb 8, 2023
Stage III Breast Cancer AJCC V7 Trial in Bergen (epirubicin/docetaxel sequential)
Active, not recruiting
- Stage III Breast Cancer AJCC V7
- epirubicin/docetaxel sequential
-
Bergen, NorwayDept of Oncology
Jun 24, 2022
HER2 Positive Early Breast Cancer Trial in Shanghai (Docetaxel, carboplatin, Trastuzumab)
Recruiting
- HER2 Positive Early Breast Cancer
- Docetaxel
- +5 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center Shanghai, China, 200032
Jun 6, 2023
Breast Tumors, Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (utidelone, docetaxel)
Not yet recruiting
- Breast Neoplasms
- Locally Advanced or Metastatic Breast Cancer
- utidelone
- docetaxel
-
Guangzhou, Gangdong, ChinaShusen Wang
Jun 21, 2022
Breast Cancer Trial in Shanghai (KN026)
Recruiting
- Breast Cancer
-
Shanghai, Shanghai, ChinaFudan University Cancer Hospital
Jun 16, 2022
Head and Neck Squamous Carcinoma Trial in Shanghai (SCT-I10A, SCT200, paclitaxel)
Recruiting
- Head and Neck Squamous Carcinoma
- SCT-I10A
- +3 more
-
Shanghai, ChinaShanghai East Hospital
Sep 22, 2022
Metastatic Castration-resistant Prostate Cancer Trial in La Jolla (Cirmtuzumab)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
-
La Jolla, CaliforniaUniversity of California San Diego
May 22, 2022
Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)
Recruiting
- Breast Cancer
- Docetaxel
- +6 more
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 28, 2022
Metastatic Castration-Resistant Prostate Cancer Patients Trial in Copenhagen (Irofulven, Prednisolone 10 mg)
Active, not recruiting
- Metastatic Castration-Resistant Prostate Cancer Patients
- Irofulven
- Prednisolone 10 mg
-
Copenhagen, DenmarkRigshospitalet, Dept. Of Oncology
Feb 1, 2023
Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)
Recruiting
- Breast Cancer
- Docetaxel
- +6 more
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 28, 2022
Non-muscle-invasive Bladder Cancer Trial (Gemcitabine, Docetaxel, Bacillus Calmette Guerin)
Not yet recruiting
- Non-muscle-invasive Bladder Cancer
- Gemcitabine
- +2 more
- (no location specified)
Sep 9, 2022
Non Small Cell Lung Cancer, NSCLC, Small-cell Lung Cancer Trial in Saint Louis (ADI-PEG 20, Gemcitabine, Docetaxel)
Not yet recruiting
- Non Small Cell Lung Cancer
- +3 more
- ADI-PEG 20
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Nov 14, 2022
Cancer Of Prostate, Prostate Tumors Trial run by the National Cancer Institute (NCI) (ADT, Prednisone, M7824)
Recruiting
- Cancer Of Prostate
- Prostate Neoplasms
- ADT
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Advanced Gastric Adenocarcinoma Trial in Seoul (AZD6094, docetaxel)
Completed
- Advanced Gastric Adenocarcinoma
- AZD6094
- docetaxel
-
Seoul, Seoul, Korea, Republic Of, Korea, Republic ofSamsung Medical Center
Jun 13, 2022
NSCLC (NSCLC) Trial in Shanghai (Tumor treating fields(EFE-P100), Docetaxel injection)
Not yet recruiting
- Non-small Cell Lung Cancer (NSCLC)
- Tumor treating fields(EFE-P100)
- Docetaxel injection
-
Shanghai, ChinaShanghai Pulmonary Hospital
Dec 21, 2022